Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Julie B. Kessel, MD

Articles by Julie B. Kessel, MD

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population

ByJulie B. Kessel, MD,Liana D. Castel, PhD,Douglas A. Nemecek, MD

February 2nd 2018

Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.

Latest Updated Articles

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population
Published: February 2nd 2018 | Updated:

Trending on Pharmacy Times

A Healthy Gut Could Improve Mental Health

FDA Approves First Oral GLP-1 for Weight Management

December 2025 Product Updates

FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia

Reimagining Pharmacy: A Call to Action for Pharmacy Professionals